-
1دورية أكاديمية
المؤلفون: Schrock AB, Madison R, Rosenzweig M, Allen JM, Erlich RL, Wang SY, Chidiac T, Reddy VS, Riess JW, Yassa AE, Shakir A, Miller VA, Alexander BM, Venstrom J, McGregor K, Ali SM
المصدر: Lung Cancer: Targets and Therapy, Vol Volume 11, Pp 33-39 (2020)
مصطلحات موضوعية: alk rearrangement, inversion, deletion, genomic profiling, targeted therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Lara, JD, Brunson, A, Riess, JW, Kelly, K, Jr, LP, Gandara, DR
المصدر: Lara, JD; Brunson, A; Riess, JW; Kelly, K; Jr, LP; & Gandara, DR. (2015). Predictors of Survival in Small Cell Lung Cancer (SCLC) Patients (pts) < 50 Years of Age: Results from the California Cancer Registry (CCR). JOURNAL OF THORACIC ONCOLOGY, 10(9), S501-S501. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/5f96j2dr
مصطلحات موضوعية: young patients, epidemiology, small cell lung cancer
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______325::6b9bdfd82d7623d98beb882618e377d3
http://www.escholarship.org/uc/item/5f96j2dr -
3دورية أكاديمية
المؤلفون: Riess JW, Logan AC, Krupitskaya Y, Padda S, Clément-Duchêne C, Ganjoo K, Colevas AD, Pedro-Salcedo MS, Kuo CJ, Wakelee HA
المصدر: Cancer Investigation; Mar2012, Vol. 30 Issue 3, p231-235, 5p
-
4دورية أكاديمية
المؤلفون: Riess JW, Nagpal S, Das M, Neal JW, Kim JW, Wakelee HA, Riess, Jonathan W, Nagpal, Seema, Das, Millie, Neal, Joel W, Kim, Jonathan W, Wakelee, Heather A
المصدر: Journal of Thoracic Oncology; 2013 Feb, Vol. 8 Issue 2, pe17-8, 1p
-
5دورية أكاديمية
المؤلفون: Riess JW, Neal JW, Riess, Jonathan W, Neal, Joel W
المصدر: Journal of Thoracic Oncology; 2012 Supplement, Vol. 7, pS385-6, 1p
-
6دورية أكاديمية
المؤلفون: Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Urisman A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Pathology, University of California, San Francisco, San Francisco, CA., Gubens MA; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Mulvey CK; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Allen GM; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Shiboski SC; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Chakrabarti T; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Aredo JV; Department of Medicine, University of California, San Francisco, San Francisco, CA., Bacaltos B; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Gee M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Tan L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Jones KD; Department of Pathology, University of California, San Francisco, San Francisco, CA., Devine WP; Department of Pathology, University of California, San Francisco, San Francisco, CA.; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA., Doebele RC; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Aisner DL; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO., Patil T; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Schenk EL; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Chan Zuckerberg Biohub, San Francisco, CA., Riess JW; Department of Medicine, University of California Davis, Sacramento, CA., Coleman M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA., Kratz JR; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA., Jablons DM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA.
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 19, pp. JCO2400071. Date of Electronic Publication: 2024 Jul 19.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
-
7دورية أكاديمية
المؤلفون: Lara MS; University of California Davis Comprehensive Cancer Center, Sacramento CA, USA., Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento CA, USA., Goldman JW; University of California Los Angeles, Los Angeles, CA, USA., Jiang F; University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco, CA, USA., Bivona TG; University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco, CA, USA., Blakely CM; University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: Collin.Blakely@ucsf.edu.
المصدر: Clinical lung cancer [Clin Lung Cancer] 2024 Jul 05. Date of Electronic Publication: 2024 Jul 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
-
8دورية أكاديمية
المؤلفون: Kulkarni AA; University of Minnesota, Minneapolis, MN. Electronic address: kulkarni@umn.edu., Hennessy C; Vanderbilt University Medical Center, Nashville, TN., Wilson G; University of Minnesota, Minneapolis, MN., Ramesh V; University of Minnesota, Minneapolis, MN., Hwang C; Henry Ford Health System, Detroit, MI., Awosika J; University of Cincinnati, Cincinnati, OH., Bakouny Z; Dana-Farber Cancer Institute, Boston, MA., Khan H; Legorreta Cancer Center at Brown University, Providence, RI., Vilar-Compte D; Instituto Nacional de Cancerologia, Mexico City, Mexico., McKay R; University of California, San Diego, CA., Jani C; Mount Auburn Hospital, Cambridge, MA., Weissmann L; Mount Auburn Hospital, Cambridge, MA., Griffiths E; Rosewell Park Comprehensive Cancer Center, Buffalo, NY., Batist G; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Canada., Bouganim N; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Canada., Mavromatis B; UPMC Western Maryland, Cumberland, MD., Bashir B; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA., Nguyen RH; University of Illinois Hospital & Health Sciences System, Chicago, IL., Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Puc M; Virtua Health, Marlton, NJ., Kasi A; University of Kansas, Kansas City, KS., Berg S; Loyola University, Chicago, IL., Castillo DR; Loma Linda University, Loma Linda, CA., Hayes-Lattin B; Oregon Health and Science University, Portland, OR., Hosmer W; Hartford HealthCare Cancer Institute, Southington, CT., Flora D; St. Elizabeth Healthcare, Edgewood, KY., Mishra S; Legorreta Cancer Center at Brown University, Providence, RI., French B; Vanderbilt University Medical Center, Nashville, TN., Warner JL; Legorreta Cancer Center at Brown University, Providence, RI., Lopes G; University of Miami, Miami, FL., Peters S; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Florez N; Dana-Farber Brigham Cancer Center, Boston, MA.
المصدر: Clinical lung cancer [Clin Lung Cancer] 2024 Jul; Vol. 25 (5), pp. e229-e237.e7. Date of Electronic Publication: 2024 Apr 10.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
مواضيع طبية MeSH: COVID-19*/epidemiology , Registries* , Thoracic Neoplasms*/drug therapy , SARS-CoV-2*, Humans ; Male ; Female ; Aged ; Middle Aged ; Antineoplastic Agents/therapeutic use
-
9دورية أكاديمية
المؤلفون: Firoz WA; UC Davis Comprehensive Cancer Center, Sacramento, CA., Sen F; Department of Radiology, University of California, Davis, Sacramento, CA., Kiuru M; Department of Dermatology, University of California, Davis, Sacramento, CA; Department of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA., Huang V; Department of Dermatology, University of California, Davis, Sacramento, CA., Riess JW; UC Davis Comprehensive Cancer Center, Sacramento, CA; Division of Hematology/Oncology, Department of Internal Medicine, University of California, Davis, Sacramento, CA. Electronic address: jwriess@ucdavis.edu.
المصدر: Clinical lung cancer [Clin Lung Cancer] 2024 Jun; Vol. 25 (4), pp. 380-383. Date of Electronic Publication: 2024 Jan 30.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Proto-Oncogene Proteins B-raf*/genetics , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Skin Neoplasms*/genetics , Skin Neoplasms*/pathology , Mutation*/genetics , Proto-Oncogene Proteins*/genetics , Protein-Tyrosine Kinases*/genetics, Humans ; Male ; Middle Aged ; Female
-
10دورية أكاديمية
المؤلفون: Haderk F; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Chou YT; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Cech L; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA., Fernández-Méndez C; Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científícas (CSIC) y Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Yu J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA., Olivas V; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Meraz IM; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barbosa Rabago D; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Gomez C; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Allegakoen DV; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Guan J; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA., Shah KN; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Herrington KA; Center for Advanced Light Microscopy, University of California, San Francisco, San Francisco, CA, USA., Gbenedio OM; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA., Nanjo S; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan., Majidi M; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tamaki W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Pourmoghadam YK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McCoach CE; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Gutkind JS; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Tang TT; Vivace Therapeutics, Inc., 1500 Fashion Island Blvd., Suite 102, San Mateo, CA, USA., Post L; Vivace Therapeutics, Inc., 1500 Fashion Island Blvd., Suite 102, San Mateo, CA, USA., Huang B; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Santisteban P; Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científícas (CSIC) y Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Goodarzi H; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA., Bandyopadhyay S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Kuo CJ; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Roose JP; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA., Wu W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Roth JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.
المصدر: Nature communications [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3741. Date of Electronic Publication: 2024 May 03.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/metabolism , Signal Transduction*/drug effects , Transcription Factors*/metabolism , Transcription Factors*/genetics , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/metabolism , Carcinoma, Non-Small-Cell Lung*/pathology , YAP-Signaling Proteins*/metabolism , Drug Resistance, Neoplasm*/genetics, Humans ; Cell Line, Tumor ; Animals ; Adaptor Proteins, Signal Transducing/metabolism ; Adaptor Proteins, Signal Transducing/genetics ; Neoplasm, Residual ; Mice ; Focal Adhesion Kinase 1/metabolism ; Focal Adhesion Kinase 1/genetics ; ErbB Receptors/metabolism ; ErbB Receptors/genetics ; Anaplastic Lymphoma Kinase/metabolism ; Anaplastic Lymphoma Kinase/genetics ; Anaplastic Lymphoma Kinase/antagonists & inhibitors ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Focal Adhesion Protein-Tyrosine Kinases/metabolism ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Xenograft Model Antitumor Assays